Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
CA 2487268 A1 · Owner: Adang, Anton Egbert Peter · Inventors: Kloosterboer, Helenius Jan; Adang, Anton Egbert Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention provides a use of tibolone and a SERM for the manufacture of a medicine for the treatment of an estrogen-deficiency related complaint for the prevention of a recurrence of breast cancer in females suffering from, or at risk for breast cancer that exhibit the estrogendeficiency related complaint.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 20, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 20, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 20, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.